Janus Henderson Group
KERX

Janus Henderson Group’s Keryx Biopharmaceuticals Inc KERX Stock Holding History

Janus Henderson Group’s Portfolio KERX Stock Details KERX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-15,046
Closed -$51K – 1466
2018
Q3 		$51K Buy
15,046
+3,200
+27% +$11.5K ﹤0.01% 1439
2018
Q2 		$45K Buy
+11,846
New +$57.7K ﹤0.01% 1386

Janus Henderson Group's KERX Position: Q4 2018 in Review

Janus Henderson Group sold out of Keryx Biopharmaceuticals Inc (KERX) in Q4 2018, closing a stake of 15,046 shares — an estimated $51K sold.

Janus Henderson Group first reported a position in KERX in Q2 2018 and held it in 2 quarters. The position peaked at $51K in Q3 2018. 1 fund tracked by Wall St. Rank holds KERX as of Q4 2018.

  • Janus Henderson Group reported no remaining Keryx Biopharmaceuticals Inc position as of Q4 2018 after selling out during the quarter.
  • Janus Henderson Group sold 15,046 Keryx Biopharmaceuticals Inc shares in Q4 2018, an estimated $51K.
  • Janus Henderson Group first reported a position in Keryx Biopharmaceuticals Inc in Q2 2018 and held it in 2 quarters.
  • Janus Henderson Group's Keryx Biopharmaceuticals Inc position peaked at $51K in Q3 2018.
  • 1 fund tracked by Wall St. Rank held Keryx Biopharmaceuticals Inc as of Q4 2018.

Based on Janus Henderson Group's 13F filing for Q4 2018, filed 6 Feb 2019.